论文部分内容阅读
目的探讨经皮肾镜气压弹道联合超声弹道碎石清石系统在肾及输尿管上段结石中的应用价值。方法选择曲靖市第一人民医院2011年10月至2013年1月泌尿外科上尿路结石患者142例作为研究对象,其中71例患者选择采用单纯经皮肾镜气压弹道清除结石,设为对照组,其余71例患者选择采用经皮肾镜气压弹道联合超声弹道碎石清石系统清除结石,设为实验组。分析并比较两组手术时间、术中出血量、术后并发症发生率、结石清除率。结果实验组的手术时间为(93.12±12.32)min、术中出血量为(50.32±15.67)ml、术后并发症发生率为4.2%,结石清除率为86.7%;对照组手术时间为(124.20±12.65)min、术中出血量为(90.23±17.81)ml、术后并发症发生率为15.5%,结石清除率为75.6%。实验组的手术时间、术中出血量、术后并发症发生率均少于对照组,结石清除率高于对照组,差异均有统计学意义(P<0.05)。结论经皮肾镜气压弹道联合超声弹道碎石清石系统对肾及输尿管上段结石清除率高,术后并发症少,值得在临床推广。
Objective To investigate the value of percutaneous nephrolithotomy combined with ultrasonic lithotripsy in the diagnosis of renal and upper ureteral calculi. METHODS: A total of 142 patients with upper urinary tract calculi in the First People’s Hospital of Qujing City from October 2011 to January 2013 were selected as the study subjects. Among them, 71 patients were treated with pneumatic percutaneous nephrolithotomy to remove stones, , The remaining 71 patients choose to use percutaneous nephroscopic pneumatic ballistic ultrasound lithotripsy clear stone system, set the experimental group. Analysis and comparison of two groups of operation time, intraoperative blood loss, postoperative complications, stone clearance rate. Results The operation time of the experimental group was (93.12 ± 12.32) min, the blood loss was (50.32 ± 15.67) ml, the postoperative complication rate was 4.2% and the stone removal rate was 86.7%. The operation time of the control group was (124.20 ± 12.32) ± 12.65) min. The blood loss in operation was (90.23 ± 17.81) ml. The incidence of postoperative complications was 15.5%. The stone clearance rate was 75.6%. The operation time, intraoperative blood loss and postoperative complications in the experimental group were less than those in the control group, and the stone clearance rate was higher than that in the control group (P <0.05). Conclusion Percutaneous nephrolithotomy combined with ultrasonic lithotripsy lithotripsy has a high clearance rate of stones in upper kidney and ureter with less postoperative complications, which is worthy of clinical promotion.